Riggs Asset Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-221
| Closed | -$3.14K | – | 685 |
|
2024
Q3 | $3.14K | Hold |
221
| – | – | ﹤0.01% | 328 |
|
2024
Q2 | $2.86K | Hold |
221
| – | – | ﹤0.01% | 342 |
|
2024
Q1 | $3.07K | Hold |
221
| – | – | ﹤0.01% | 320 |
|
2023
Q4 | $3.15K | Hold |
221
| – | – | ﹤0.01% | 308 |
|
2023
Q3 | $3.42K | Hold |
221
| – | – | ﹤0.01% | 314 |
|
2023
Q2 | $3.47K | Hold |
221
| – | – | ﹤0.01% | 303 |
|
2023
Q1 | $3.64K | Hold |
221
| – | – | ﹤0.01% | 278 |
|
2022
Q4 | $3.45K | Hold |
221
| – | – | ﹤0.01% | 250 |
|
2022
Q3 | $3K | Hold |
221
| – | – | ﹤0.01% | 277 |
|
2022
Q2 | $3K | Hold |
221
| – | – | ﹤0.01% | 263 |
|
2022
Q1 | $3K | Hold |
221
| – | – | ﹤0.01% | 282 |
|
2021
Q4 | $3K | Hold |
221
| – | – | ﹤0.01% | 290 |
|
2021
Q3 | $4K | Hold |
221
| – | – | ﹤0.01% | 279 |
|
2021
Q2 | $4K | Hold |
221
| – | – | ﹤0.01% | 277 |
|
2021
Q1 | $4K | Hold |
221
| – | – | ﹤0.01% | 249 |
|
2020
Q4 | $4K | Hold |
221
| – | – | ﹤0.01% | 233 |
|
2020
Q3 | $3K | Hold |
221
| – | – | ﹤0.01% | 155 |
|
2020
Q2 | $3K | Hold |
221
| – | – | ﹤0.01% | 218 |
|
2020
Q1 | $3K | Hold |
221
| – | – | ﹤0.01% | 221 |
|
2019
Q4 | $4K | Hold |
221
| – | – | ﹤0.01% | 249 |
|
2019
Q3 | $3K | Hold |
221
| – | – | ﹤0.01% | 216 |
|
2019
Q2 | $4K | Hold |
221
| – | – | ﹤0.01% | 220 |
|
2019
Q1 | $4K | Buy |
+221
| New | +$4K | ﹤0.01% | 208 |
|